Economics
Title
Date Published
Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty.
July 23, 2013
Utility and cost of low-vacuum reinfusion drains in patients undergoing surgery for subcapital hip fracture repair. A before and after cohort study.
July 22, 2013
Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.
July 16, 2013
Costs of delivering allogenic blood in hospitals. [Article in German]
May 1, 2013
Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice.
April 30, 2013
Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis.
April 18, 2013
Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
April 15, 2013
The costs of transfusion: economic evaluations in transfusion medicine, Part 1.
April 8, 2013
The HI-STAR study: resource utilization and costs associated with serologic testing for antibody-positive patients at four United States medical centers.
April 3, 2013
The burden of blood transfusion: a utilization and economic analysis – a pilot study in patients with chemotherapy-induced anemia (CIA).
March 19, 2013
Economic considerations on transfusion medicine and patient blood management.
March 1, 2013
Clinical and economic outcomes associated with blood transfusions among elderly Americans following coronary artery bypass graft surgery requiring cardiopulmonary bypass.
February 6, 2013
The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures.
November 7, 2012
Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery.
July 30, 2012
Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need.
April 9, 2012
Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
April 9, 2012
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic.
March 2, 2012
From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice
February 29, 2012
A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.
February 17, 2012
The cost of blood transfusion in Western Europe as estimated from six studies.
February 8, 2012